Literature DB >> 20607803

Transcriptional activity of TAp63 promoter is regulated by c-jun.

Jeng-Yuan Yao1, Chia-Chu Pao, Jan-Kan Chen.   

Abstract

The transcription factor p63 belongs to the p53 protein family and plays an important role in epithelial development. Recent studies showed that p63 is over-expressed in some human squamous cell carcinomas of the head and neck, suggesting a role in carcinogenesis. The p63 gene contains two promoters and alternative promoter usage generates two groups of proteins with (TAp63) or without (ΔNp63) the transactivation domain. Although the roles of TAp63 in epithelial development have been described in numerous recent studies, the regulation of its expression has not been elucidated. In this study, we showed that the transcriptional activity of the TAp63 promoter and TAp63 protein level were both up-regulated by an increased c-jun activity in Hep3B human hepatocellular carcinoma cell. Moreover, the elevated TAp63 expression was coincided with an increased binding of c-jun to the TAp63 promoter. Point mutation of the sp1 binding site within the TAp63 promoter region attenuated the effect of c-jun on TAp63 expression. Knockdown of TAp63 expression by shRNA led to increased proliferation of Hep3B cell compared to that of the mock cell, suggesting a growth suppressive effect of TAp63.
© 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20607803     DOI: 10.1002/jcp.22300

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  4 in total

1.  Role of p63 in Development, Tumorigenesis and Cancer Progression.

Authors:  Johann Bergholz; Zhi-Xiong Xiao
Journal:  Cancer Microenviron       Date:  2012-07-31

2.  Highly expressed histone deacetylase 5 promotes the growth of hepatocellular carcinoma cells by inhibiting the TAp63-maspin pathway.

Authors:  Hongqian Gu; Zejun Fang; Xiang Cai; Rui Song; Min Lin; Jiangwei Ye; Xiaokun Ding; Qinjian Ke; Haihong Chen; Chaoju Gong; Ming Ye
Journal:  Am J Cancer Res       Date:  2018-03-01       Impact factor: 6.166

3.  A neuroprotective agent that inactivates prodegenerative TrkA and preserves mitochondria.

Authors:  Konstantin Feinberg; Adelaida Kolaj; Chen Wu; Natalie Grinshtein; Jonathan R Krieger; Michael F Moran; Lee L Rubin; Freda D Miller; David R Kaplan
Journal:  J Cell Biol       Date:  2017-09-06       Impact factor: 10.539

Review 4.  Aberrant expression of alternative isoforms of transcription factors in hepatocellular carcinoma.

Authors:  Olga Krivtsova; Anna Makarova; Natalia Lazarevich
Journal:  World J Hepatol       Date:  2018-10-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.